cdmo.directory
← Home
ten23 health AG logo

ten23 health AG

Sterile solutions, built differently.

Swiss sterile injectables CDMO offering formulation and analytical development, aseptic syringe, cartridge and vial fill-finish, and QC testing from Basel and Visp. Holds Swissmedic ATMP GMP licenses and has FDA-approved QC laboratories. Headquartered in Basel, Switzerland.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Regulatory clearances

Services

About this organization

Overview

ten23 health is a science-led, Patient-focused CDMO for sterile injectable medicines. The company describes itself as a strategic partner for pharmaceutical companies and biotech start-ups in formulation, analytical and process development, sterile manufacturing (fill and finish), and testing of injectable treatments.

Services

  • Development strategy and formulation design, including administration, compatibility and usability work
  • Drug/device integration and molecule selection and characterization
  • Analytical development and testing, and packaging and device characterization
  • Troubleshooting and regulatory support
  • Manufacturing process transfer, characterization and validation
  • Clinical fill and finish and commercial supplies
  • Stability and pre-clinical supplies

Manufacturing and quality

  • Sites in Basel and Visp, Switzerland
  • Swissmedic GMP licenses for manufacturing and testing of Advanced Therapy Medicinal Products (ATMP) at both Basel and Visp facilities
  • Quality Control laboratories in Basel and Visp, formally approved by the U.S. Food and Drug Administration
  • A large-scale Annex 1 compliant aseptic filling line (Line 2) at the Visp VIVA2 facility for syringe, cartridge and vial filling
  • Device assembly capability for large-volume wearable injectors, through a partnership with Ypsomed

Partnerships and differentiation

  • Full-service supply readiness for the BD Libertas wearable injector
  • Prefillable syringe system testing on its equipment for the West Synchrony S1 system
  • Research collaboration with dsm-firmenich on excipients for parenteral biologic drug products

ten23 health describes itself as the first CDMO for injectables and sterile drug products to be certified as a B Corp.

Locations

  • Basel

    Basel · Switzerland

  • Visp

    Visp · Switzerland

  • Tokyo

    Tokyo · Japan

Similar profiles by shared services, modalities, and capabilities.

View all alternatives →See similar CDMOs ranked by shared capabilities

Submit a verified review for this organization.

Markdown mirror: /companies/ten23-health.md